Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.
The Lancet Neurology, March 2016
BACKGROUND: Almost a third of patients with epilepsy have a treatment-resistant form, which is associated with severe morbidity and increased mortality. Cannabis-based treatments for epilepsy have generated much interest, but scientific data are scarce. We aimed to establish w…